A Retrospective Study of Focal Segmental Glomerulosclerosis: Clinical Criteria Can Identify Patients at High Risk for Recurrent Disease After First Renal Transplantation

Overview

Journal BMC Nephrol

Publisher Biomed Central

Specialty Nephrology

Date 2013 Feb 26

PMID 23433074

Citations 26

Authors

Rutger J H Maas

Jeroen K J Deegens

Jan A J G van den Brand

Elisabeth A M Cornelissen

Jack F M Wetzels

Affiliations

Soon will be listed here.

Abstract

Background: Focal segmental glomerulosclerosis (FSGS) is a frequent cause of end-stage renal disease. Renal transplantation in patients with FSGS is often complicated by disease recurrence, which is associated with poor outcome. There are no tests that reliably predict recurrence of FSGS after transplantation. The aim of this study was to evaluate if clinical criteria can identify patients at high risk for recurrent disease.

Methods: We retrospectively studied 94 patients who received a first renal transplant at a median age of 37 years (range 5-69 years). Patients were assigned to one of three groups: familial or genetic FSGS (group I; n=18), secondary FSGS (group II; n=10) and idiopathic FSGS (group III; n=66). Pretransplant clinical characteristics were analyzed to determine predictors of a recurrence after transplantation.

Results: FSGS only recurred in patients with idiopathic FSGS (group III; 42%). Patients with a recurrence had a significantly lower serum albumin, higher 24-hour proteinuria and higher estimated glomerular filtration rate at diagnosis. Serum albumin at diagnosis was the only independent predictor of a recurrence in patients with idiopathic FSGS. Patients with recurrent FSGS had more acute rejection episodes (54% vs. 27%, P =0.02) and lower five year graft survival compared to patients without a recurrence (50 vs. 82%, P <0.01).

Conclusions: Clinical criteria allow identification of patients at high risk of recurrent FSGS after renal transplantation. This information can be used in the counseling and management of patients with FSGS.

Citing Articles

Glomerulonephritis After Renal Transplatation in South Asia - Single Center Experience Over 5 Decades.

Yusuf S, Alexander S, Roy S, Rebekah G, John E, Thomas A Indian J Nephrol. 2025; 35(2):270-276.

PMID: 40060067 PMC: 11883335. DOI: 10.25259/IJN_39_2024.

Steroid-Resistant Nephrotic Syndrome due to Variants Is Not Associated With Posttransplant Recurrence.

Kachmar J, Boyer O, Lipska-Zietkiewicz B, Moriniere V, Gribouval O, Heidet L Kidney Int Rep. 2024; 9(4):973-981.

PMID: 38765578 PMC: 11101709. DOI: 10.1016/j.ekir.2024.01.005.

Precision medicine for focal segmental glomerulosclerosis.

Xie Y, Liu F Kidney Res Clin Pract. 2024; 43(6):709-723.

PMID: 38325863 PMC: 11615440. DOI: 10.23876/j.krcp.23.227.

The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).

Bose B, Milanzi E, Pascoe E, Johnson D, Badve S PLoS One. 2023; 18(11):e0293721.

PMID: 37917639 PMC: 10621846. DOI: 10.1371/journal.pone.0293721.

Incidence and risk factors for recurrent focal segmental glomerulosclerosis after kidney transplantation: a meta-analysis.

Bai J, Zhang T, Wang Y, Cao J, Duan Z, Ji L Ren Fail. 2023; 45(1):2201341.

PMID: 37070350 PMC: 10120546. DOI: 10.1080/0886022X.2023.2201341.

References

Connor A, Highton J, Hung N, Dunbar J, MacGinley R, Walker R . Multicentric carpal-tarsal osteolysis with nephropathy treated successfully with cyclosporine A: a case report and literature review. Am J Kidney Dis. 2007; 50(4):649-54. DOI: 10.1053/j.ajkd.2007.06.014. View

Hariharan S, Adams M, Brennan D, Davis C, First M, Johnson C . Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation. 1999; 68(5):635-41. DOI: 10.1097/00007890-199909150-00007. View

Senggutuvan P, Cameron J, Hartley R, Rigden S, Chantler C, Haycock G . Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol. 1990; 4(1):21-8. DOI: 10.1007/BF00858431. View

Cheong H, Han H, Park H, Ha I, Han K, Lee H . Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant. 1999; 15(1):78-81. DOI: 10.1093/ndt/15.1.78. View

Schwartz G, Brion L, Spitzer A . The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987; 34(3):571-90. DOI: 10.1016/s0031-3955(16)36251-4. View

Ponticelli C . Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant. 2009; 25(1):25-31. DOI: 10.1093/ndt/gfp538. View

Yang H, Fogo A . 'Idiopathic' FSGS: an increasingly obsolete diagnosis?. Nephrol Dial Transplant. 2010; 25(3):654-6. DOI: 10.1093/ndt/gfp750. View

Pinto J, LACERDA G, Cameron J, Turner D, Bewick M, Ogg C . Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation. 1981; 32(2):83-9. DOI: 10.1097/00007890-198108000-00001. View

Salomon R, Gagnadoux M, Niaudet P . Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation. 2003; 75(6):810-4. DOI: 10.1097/01.TP.0000055215.20367.21. View

10.

Deegens J, Andresdottir M, Croockewit S, Wetzels J . Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transpl Int. 2004; 17(3):151-7. DOI: 10.1007/s00147-003-0679-y. View

11.

Garcia C, Bittencourt V, Tumelero A, Antonello J, Malheiros D, Garcia V . Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis. Transplant Proc. 2006; 38(6):1904-5. DOI: 10.1016/j.transproceed.2006.06.069. View

12.

Kaplan-Pavlovcic S, Ferluga D, Hvala A, Bren A, Vizjak A . Recurrent focal segmental glomerulosclerosis after renal transplantation: is early recurrent proteinuria always a surrogate marker for recurrence of the disease?. Transplant Proc. 2002; 34(8):3122-4. DOI: 10.1016/s0041-1345(02)03667-9. View

13.

White I, Royston P, Wood A . Multiple imputation using chained equations: Issues and guidance for practice. Stat Med. 2011; 30(4):377-99. DOI: 10.1002/sim.4067. View

14.

Couser W . Recurrent glomerulonephritis in the renal allograft: an update of selected areas. Exp Clin Transplant. 2005; 3(1):283-8. View

15.

Banfi G, Colturi C, Montagnino G, Ponticelli C . The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation. 1990; 50(4):594-6. DOI: 10.1097/00007890-199010000-00013. View

16.

McNutt L, Wu C, Xue X, Hafner J . Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol. 2003; 157(10):940-3. DOI: 10.1093/aje/kwg074. View

17.

Ingulli E, Tejani A . Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience. Transplantation. 1991; 51(2):401-5. DOI: 10.1097/00007890-199102000-00025. View

18.

Deegens J, Steenbergen E, Wetzels J . Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth J Med. 2008; 66(1):3-12. View

19.

Schachter M, Monahan M, Radhakrishnan J, Crew J, Pollak M, Ratner L . Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression. Clin Nephrol. 2010; 74(3):173-81. DOI: 10.5414/cnp74173. View

20.

Pardon A, Audard V, Caillard S, Moulin B, Desvaux D, Bentaarit B . Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant. 2005; 21(4):1053-9. DOI: 10.1093/ndt/gfk005. View